In HPV+ tumors, fibroblast growth factor receptor genes such as FGFR3 have previously been found to be enriched for mutations [17], but the high intensity of their effect on the proliferation and survival of cancer cell lineages has not previously been quantified relative to other somatic nucleotide mutations. Here, FGFR3 is linked to cancer.